Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
QuintilesIMS
Healthtrust
UBS
Deloitte
US Department of Justice
Dow
Baxter

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PERAMPANEL

« Back to Dashboard

Clinical Trials for Perampanel

Trial ID Title Status Sponsor Phase Summary
NCT00368472 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures Completed Eisai Inc. Phase 2 The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures.
NCT00505284 An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Limited Phase 2/Phase 3 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
NCT00505284 An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Inc. Phase 2/Phase 3 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Perampanel

Condition Name

Condition Name for Perampanel
Intervention Trials
Epilepsy 10
Refractory Partial Seizures 4
Healthy Subjects 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Perampanel
Intervention Trials
Seizures 17
Epilepsy 14
Epilepsies, Partial 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Perampanel

Trials by Country

Trials by Country for Perampanel
Location Trials
United States 137
Japan 41
China 16
Canada 12
Spain 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Perampanel
Location Trials
Florida 8
New York 8
Maryland 7
Colorado 7
Texas 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Perampanel

Clinical Trial Phase

Clinical Trial Phase for Perampanel
Clinical Trial Phase Trials
Phase 4 8
Phase 3 11
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Perampanel
Clinical Trial Phase Trials
Completed 20
Recruiting 10
Not yet recruiting 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Perampanel

Sponsor Name

Sponsor Name for Perampanel
Sponsor Trials
Eisai Inc. 30
Eisai Co., Ltd. 7
Eisai Limited 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Perampanel
Sponsor Trials
Industry 42
Other 12
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Fish and Richardson
Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
Mallinckrodt
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.